Check out your Company Bowl for anonymous work chats.
❤️ Today on #WearRedDay, we share the importance of heart failure (HF) education and support interventions for women to improve HF prevention strategies and medication management. Read recent study results based on data from participants of the American Heart Association's Research Goes Red registry, powered by Verily.
2025 will be an exciting year for Verily as we bring new products to market that realize our precision health vision. Through the Verily platform, we can: ✳️ Help customers activate their data directly in care environments and research workflows ✳️ Provide access to a unique data ecosystem to enrich and enhance customer data ✳️ Use AI to help automate tasks, scale expertise, and to turn data to insight In the blog, Verily in ’25 and beyond, our CEO Stephen Gillett details how our solutions provide the data and tech to unlock the promise of AI and data science to improve healthcare.
Discover the future of protocol management with Verily's patented, AI- driven technology. This introduction to protocol digitization explores how automation enhances accuracy and efficiency across industries.
How will AI impact the biopharma industry in 2025? Verily Chief Medical and Scientific Officer Andrew Trister shared his predictions about how AI will be applied to data and to clinician decision-making with Citeline SCRIP.
Clinical trial protocols are long, static documents, requiring sponsors to manually configure data across many systems, leading to inefficiencies and extended timelines. The use of AI/LLM agents to digitize protocols optimizes research for sponsors and sites. Verily’s Lauren Sutton and Yugang Jia explain how at SCOPE on Tuesday, February 6th at 11:55 AM ET.
Andrew Trister, Verily Chief Medical and Scientific Officer, will be speaking at the PMWC Precision Medicine World Conference on February 6 during the session, AI-Powered RWE: Accelerating Drug Development and Post-Market Applications. He’ll join fellow experts Michelle Chen, Jun Jeon, Dan Riskin and moderator Erik Reinertsen to explore AI-driven drug development.
Health data is precious. It's personal. It needs to be protected at the highest level. As a company who partners with life sciences, health plans, employers, and consumers, we take health data protection very seriously. Thank you to the security experts at Verily who make sure the health data we manage is protected, governed, and safe.
The eye is the window into human health. Superior Health and Verily are partnering to bring advanced retinal screenings to the Rio Grande Valley, a region with one of the highest diabetes rates in the US. Learn how this initiative is transforming eye care access for this underserved community in the next episode of our N of 1 series, Eye on the Future.
Verily Clinical Pharmacist, Denise Mackenzie, has dedicated her career to creating relationships with her patients, helping them overcome personal barriers to better medication outcomes, and drawing from her own experience managing diabetes. She serves as a partner and bridge, connecting virtual, chronic care members to the tools, resources, information, and support they need to lead healthier lives. Learn about her passion for providing more personal, precise care.
This week at the JPM Healthcare Conference, our CEO Stephen Gillett presented Verily’s vision, strategy, and business updates. ➡ At the heart, Verily is a health tech company that brings together the power of AI, our data platform technology, and a deep understanding of data at scale to build solutions that have a meaningful impact on precision health. ➡ 97% of all healthcare data is not being used to inform decisions. Verily’s goal is to harmonize and activate this data at scale, so that customers can generate insights to make healthcare more personal and precise. ➡ The core of Verily’s DNA is our understanding of AI and large datasets, and how they can be applied to deliver more precise healthcare solutions for our customers and patient populations.
